The diagnostic value of 18F-FDG PET/CT scanning for discriminating malignant from non-malignant causes in unilateral pleural effusions

S. Reuter (Naestved, Denmark), B. Fischer (Copenhagen, Denmark), P. Clementsen (Roskilde, Denmark), U. Bødtger (Naestved, Denmark)

Source: International Congress 2018 – Imaging of various diseases with different imaging modalities
Session: Imaging of various diseases with different imaging modalities
Session type: Thematic Poster
Number: 863
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Reuter (Naestved, Denmark), B. Fischer (Copenhagen, Denmark), P. Clementsen (Roskilde, Denmark), U. Bødtger (Naestved, Denmark). The diagnostic value of 18F-FDG PET/CT scanning for discriminating malignant from non-malignant causes in unilateral pleural effusions. 863

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The added value of computed tomography to thoracentesis and chest x-ray for discriminating malignant from non-malignant causes in unilateral pleural effusions
Source: International Congress 2018 – Imaging of various diseases with different imaging modalities
Year: 2018

Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 755s
Year: 2007

Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018

The usefulness of dynamic CT and 18F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule
Source: Eur Respir J 2007; 30: Suppl. 51, 532s
Year: 2007

Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion.
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

Diagnostic yield of computed tomography for idiophatic pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 774s
Year: 2006

Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer
Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation
Year: 2015



The value of thoracoscopy in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 516s
Year: 2001

PET predicts survival in malignant pleural mesothelioma
Source: ISSN=ISSN 1810-6838, ISBN=, page=290
Year: 2007

Sonographic echogenic swirling pattern in patients with malignancies: a useful diagnostic predictor for malignant pleural effusions
Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases
Year: 2008

Malignant pleural mesothelioma: CT findings in 49 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 271s
Year: 2002

Evaluation of pleural disease with FDG-PET imaging
Source: Annual Congress 2003 - Early lung cancer diagnosis
Year: 2003


The role of 99m-Tc-Depreotide scintigraphy in discriminating between malignant and benign pulmonary nodules
Source: Eur Respir J 2005; 26: Suppl. 49, 492s
Year: 2005

Prognostic value of metabolic imaging in non small cell lung cancers with neoplasic pleural effusion
Source: Eur Respir J 2007; 30: Suppl. 51, 206s
Year: 2007

The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
Source: Eur Respir J 2011; 37: 162-168
Year: 2011



Imaging guided pleural biopsies in unexplained pleural effusions
Source: Eur Respir J 2007; 30: Suppl. 51, 667s
Year: 2007

Combined pleural CRP and chest ultrosonography for discrimination between tuberculous and malignant pleural effusion
Source: Eur Respir J 2005; 26: Suppl. 49, 414s
Year: 2005